GM27381
iPSC from Fibroblast
Description:
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
N-GLYCANASE 1; NGLY1
MALIGNANT HYPERTHERMIA SUSCEPTIBILITY 5; MHS5
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1S SUBUNIT; CACNA1S
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases PIGI Consented Sample |
Protocols |
Protocol PDF |
Biopsy Source
|
Skin
|
Cell Type
|
Stem cell
|
Cell Subtype
|
Induced pluripotent stem cell
|
Transformant
|
Reprogrammed (Sendai)
|
Sample Source
|
iPSC from Fibroblast
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Country of Origin
|
USA
|
Family Member
|
1
|
Family History
|
Y
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
ISCN
|
46,XY[25].arr(1-22)x2,(X,Y)x1
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
19 |
|
Induced Pluripotent Stem Cell |
The parental cell line was recovered, reprogrammed to an induced pluripotent stem cell line, and expanded. The expanded line was evaluated for viability surface antigen expression and alkaline phosphatase activity. Pluripotency was assessed via embryoid body (EB) formation. Steady-state mRNA expression patterns of undifferentiated iPSC and EBs were determined via real-time PCR. Characterization data are included in the Certificate of Analysis. |
|
Gene |
NGLY1 |
Chromosomal Location |
3p24.2 |
Allelic Variant 1 |
p.Q208X; CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
|
Identified Mutation |
GLN208TER |
|
Gene |
NGLY1 |
Chromosomal Location |
3p24.2 |
Allelic Variant 1 |
p.G310G; CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG |
Identified Mutation |
GLY310GLY; The NGLY1 gene encodes N-glycanase (EC 3.5.1.52), a highly conserved enzyme that catalyzes deglycosylation of misfolded N-linked glycoproteins by cleaving the glycan chain before the proteins are degraded by the proteasome (Zhou et al., 2006). NGLY1 is a cytoplasmic component of the endoplasmic reticulum-associated degradation (ERAD) pathway that identifies and degrades misfolded glycoproteins (summary by Enns et al., 2014). |
|
Gene |
CACNA1S |
Chromosomal Location |
1q32.1 |
Allelic Variant 1 |
; MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5 |
Identified Mutation |
THR1354SER; The major type of voltage-sensitive Ca(2+) channels in skeletal muscle is the slowly inactivating L-type that is sensitive to calcium channel blockers such as 1,4-dihydropyridines (DHP), phenylalkylamines, and benzothiazepines. These skeletal muscle Ca(2+) channels play a key role in excitation-contraction coupling, a process whereby electrical signals generated by action potentials at the muscle cell surface are transduced into intracellular release of calcium and ultimately muscle fiber contraction. The DHP-sensitive L-type Ca(2+) channel from skeletal muscle is an oligomeric protein composed of 2 high molecular weight polypeptide subunits (alpha-1 and alpha-2) and 3 smaller units (beta, gamma, and delta). |
Remarks |
Clinically affected; onset of symptoms at 12 months old; diagnosed at 10 years of age; ataxia; cerebral palsy; hypotonia; hand tremors; developmental delay; myopathic facial expression; whole exome sequence analysis reveals the subject is compound heterozygous for a p.Q208X variant (p.Gln208Stop, c.622 C>T) in exon 4 and a p.G310G variant (p.Gly310Gly, c.930 C>T) in exon 6 of the NGLY1 gene; subject also found to be heterozygous for a c.4060 A>T mutation (Thr1354Ser) in the CACNA1S gene – (malignant hyperthermia susceptibility; reported as ACMG incidental finding). Test was performed using genomic DNA, the whole exome sequence was mapped and analyzed in comparison with the published human genome build UCSC hg19 reference sequence; father (not in repository) is heterozygous for the Q208X mutation in the NGLY1 gene; mother (not in repository) is heterozygous for the G310G mutation in the NGLY1 gene and heterozygous for the Thr1354Ser mutation in the CACNA1S gene; sister with similar phenotype and the same genetic test results as this subject is GM25331 (lymphoblast) and GM25343 (fibroblast); same subject as GM25330 (lymphoblast) and GM25344 (fibroblast). Note: Cell line has potential for increased spontaneous differentiation. Please contact the Stem Cell Laboratory at stemcellbiobank@coriell.org for additional instructions. Researchers purchasing hiPSCs from the NIGMS Repository are responsible for any limited use label licenses (LULLs) applicable to the cell line purchased. The applicable LULL to this line is Sendai-CytoTune. |
Gene Cards |
CACNA1S |
|
NGLY1 |
Gene Ontology |
GO:0005509 calcium ion binding |
|
GO:0005624 membrane fraction |
|
GO:0005891 voltage-gated calcium channel complex |
|
GO:0006812 cation transport |
|
GO:0006816 calcium ion transport |
|
GO:0006936 muscle contraction |
|
GO:0015270 dihydropyridine-sensitive calcium channel activity |
|
GO:0016021 integral to membrane |
NCBI Gene |
Gene ID:779 |
NCBI GTR |
114208 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1S SUBUNIT; CACNA1S |
|
601887 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5; MHS5 |
|
610661 N-GLYCANASE 1; NGLY1 |
|
615273 CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG |
OMIM |
114208 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1S SUBUNIT; CACNA1S |
|
601887 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5; MHS5 |
|
610661 N-GLYCANASE 1; NGLY1 |
|
615273 CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG |
Passage Frozen |
19 |
Split Ratio |
1:6 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Ham's F12 Medium/Dulbecco Modified Eagles Medium, 1:1 mixture with 2mM L-glutamine or equivalent |
Serum |
20% Knock-out Serum Replacement Not inactivated |
Substrate |
Gelatin + Feeder Layer |
Supplement |
Basic Fibroblast Growth Factor 10ng/ml |
|
|